Bayer AG

GPTKB entity

Properties (56)
Predicate Object
gptkbp:instanceOf gptkb:Company
gptkbp:acquisition gptkb:Monsanto_Company
gptkb:Covestro_AG
gptkb:Pharmaceuticals_division_of_Schering_AG
gptkb:Asklepios_BioPharmaceutical
2018
BlueRock Therapeutics
Bayer's_acquisition_of_the_rights_to_the_drug_Vitrakvi.
Bayer's_acquisition_of_the_rights_to_the_drug_Eylea.
Bayer's_acquisition_of_the_rights_to_the_drug_Kovaltry.
Bayer's_acquisition_of_the_rights_to_the_drug_Stivarga.
Bayer's_acquisition_of_the_rights_to_the_drug_Xofigo.
gptkbp:CEO gptkb:Werner_Baumann
gptkbp:employees approximately 100,000 (2020)
gptkbp:founded 1863
gptkbp:founder gptkb:Friedrich_Bayer
gptkbp:global_presence operations in over 80 countries
gptkbp:headquarters gptkb:Leverkusen,_Germany
https://www.w3.org/2000/01/rdf-schema#label Bayer AG
gptkbp:industry pharmaceuticals
agricultural chemicals
gptkbp:is_part_of DAX_index
gptkbp:market global market leader in consumer health products
global market leader in crop science
global market leader in pharmaceuticals
gptkbp:partnerships gptkb:Evotec_AG
gptkb:Ceres_Global_Ag_Corp.
gptkb:CRISPR_Therapeutics
gptkb:Ginkgo_Bioworks
Kymab
gptkbp:philanthropy gptkb:Bayer_Foundation
gptkb:Bayer_Science_&_Education_Foundation
gptkb:Bayer_HealthCare_Foundation
gptkb:Bayer_CropScience_Foundation
gptkb:Bayer_Cares_Foundation
gptkbp:products gptkb:Xarelto
Aspirin
Claritin
Advil
gptkbp:research_focus animal health
oncology
radiology
women's health
ophthalmology
cardiovascular
gptkbp:revenue approximately €43 billion (2020)
gptkbp:stockExchange gptkb:Frankfurt_Stock_Exchange
gptkbp:stockSymbol BAYN
gptkbp:subsidiary gptkb:Bayer_CropScience
gptkb:Bayer_HealthCare
gptkbp:sustainability_initiatives Promote sustainable agriculture
Improve access to healthcare
Carbon neutrality by 2030
Reduce greenhouse gas emissions by 30% by 2030
Increase biodiversity in agricultural practices
Bayer's_Sustainability_Program